Gregory Vladimer
Allcyte.com
0000-0003-4205-7585
Allcyte GmbH
2 papers found
Refreshing results…
Selective Inhibition of Bruton’s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL
Missing publications? Search for publications with a matching author name.